Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence.RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.Alternative dosing schedules and administration updates for ixabepilone.Epothilones in the treatment of ovarian cancer.Global experience with ixabepilone in breast cancer.Ixabepilone for the treatment of breast cancer.Ixabepilone: clinical role in metastatic breast cancer.The paradox of triple negative breast cancer: novel approaches to treatment.Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance.Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients
P921
Q33762423-395710EB-D460-4A8F-BE50-7271C4B1CCB9Q34788890-FA763867-3FC5-4100-B908-4F5F891B9FB1Q35076330-FADCA1A6-E7AC-4C2B-8AE1-4A7A61E00E72Q36308299-FD924A36-2ADC-49DF-934B-CD67436DD20BQ37705677-675DE98D-15AE-471F-8168-BA76A821ADFBQ37861204-E058122C-ED87-428A-AAAF-22DDF85EC0A9Q37873462-376446B2-EA29-40E2-98BB-E4B4EC2EB366Q37876407-A9C0A8BB-1582-45C0-91FA-167FA988F62FQ37888203-4305184C-CBB3-4AE7-B712-6E5F45371DBCQ37958063-A50C488F-3DB0-4F93-BAB6-B4EF4958FA63Q37963559-B9F011C3-8496-480D-8C0E-B78E5E1FA1F8Q38484152-CE6776A8-72FB-4E2F-BE89-976D25329DFEQ39603523-449EDB45-4E69-4EC6-821C-A55E665376DDQ48666084-A88F248A-740C-427E-9BB4-9FA435211B9DQ82072220-F1FEF7DD-9F51-44A8-8604-CFEBB3A21D24
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Iksabepilon
@sh
Iksabepilon
@sr
Ixabepilone
@vi
Ixabepilonă
@ro
iksabepilon
@pl
ixabepilone
@en
إكسابيبيلون
@ar
イクサベピロン
@ja
type
label
Iksabepilon
@sh
Iksabepilon
@sr
Ixabepilone
@vi
Ixabepilonă
@ro
iksabepilon
@pl
ixabepilone
@en
إكسابيبيلون
@ar
イクサベピロン
@ja
altLabel
Aza-epothilone B
@en
Azaepothilone B
@en
BMS-247550
@en
BMS-247550-01
@en
Ixabepilone
@en
Ixempra Kit
@en
Ixempra
@en
prefLabel
Iksabepilon
@sh
Iksabepilon
@sr
Ixabepilone
@vi
Ixabepilonă
@ro
iksabepilon
@pl
ixabepilone
@en
إكسابيبيلون
@ar
イクサベピロン
@ja
P592
P6366
P661
P662
P665
P683
P1579
P2017
C[C@H]1CCC[C@@]2([C@@H](O2)C[C ...... (C)C)O)/C(=C/C3=CSC(=N3)C)/C)C
P2067
506.281443
P2115
N0000176119
P2275
ixabepilone
@en
P231
219989-84-1